Bradley Mike
Department of Radiology, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
Ultrasound. 2015 Nov;23(4):212-5. doi: 10.1177/1742271X15608214. Epub 2015 Sep 28.
The aim of this study was to evaluate whether compression elastography has a useful role in the planning of percutaneous ultrasound-guided biopsies of soft tissue tumours. Consecutive patients were evaluated in the sarcoma clinic after their initial imaging work-up, involving ultrasound and MR. The multi-disciplinary team decided when percutaneous biopsy for histology was required, and this was performed in the multi-disciplinary clinic using ultrasound guidance. An experienced sarcoma radiologist performed the ultrasound with compression elastography in all cases. Grey scale imaging was used to predict the needle track for each biopsy and routinely, two passes were made into each lesion. In this study, the track for the second pass was predicted from the elastogram, aiming for a stiff (blue) area within the lesion. The samples were separately potted in formalin and sent to the sarcoma pathologist. Pathology reports for each sample were assessed to evaluate whether the elastographic blue targets yielded any specific diagnostic quality; 157 biopsies were performed in separate patients, including two passes per patient as per routine protocol; 107 (68.1%) were benign lesions and 50 (31.9%) were malignancies. In the benign group, 16 (14.9%) showed significant blue areas in the lesion. However, nine of these were thought to be artefactual, as they showed grey scale characteristics of complex cysts. Positive histology was recorded in all the blue areas, but in the benign lesions positivity was not seen solely in the blue areas; 14 (28%) in the malignant group showed blue areas in the lesion and five biopsies were positive in blue areas only. Overall, the blue target yielded the only positive tissue in 10% of the malignancies, equating to 3% of the whole study population. The p value was 0.008829 for positive histology for malignancy from blue areas only.
本研究的目的是评估弹性成像技术在软组织肿瘤经皮超声引导活检的规划中是否具有实用价值。连续的患者在肉瘤门诊进行了初步影像学检查(包括超声和磁共振成像)后接受评估。多学科团队决定何时需要进行经皮组织活检,活检在多学科门诊使用超声引导进行。所有病例均由一位经验丰富的肉瘤放射科医生进行超声弹性成像检查。使用灰阶成像预测每次活检的针道,通常对每个病变进行两次穿刺。在本研究中,第二次穿刺的针道根据弹性图预测,目标是病变内的硬(蓝色)区域。样本分别用福尔马林固定并送至肉瘤病理学家处。评估每个样本的病理报告,以评估弹性成像的蓝色靶点是否产生任何特定的诊断质量;对157名不同患者进行了活检,按照常规方案每位患者进行两次穿刺;107例(68.1%)为良性病变,50例(31.9%)为恶性病变。在良性组中,16例(14.9%)病变显示有明显的蓝色区域。然而,其中9例被认为是伪像,因为它们显示出复杂囊肿的灰阶特征。所有蓝色区域组织学检查均为阳性,但在良性病变中并非仅在蓝色区域出现阳性;恶性组中有14例(28%)病变显示蓝色区域,5例活检仅在蓝色区域为阳性。总体而言,蓝色靶点在10%的恶性肿瘤中获得了唯一的阳性组织,相当于整个研究人群的3%。仅蓝色区域恶性肿瘤组织学检查阳性的p值为0.008829。